Duncan Bucknell
Strategic Intellectual Property
Menu
Our Services
Insights & News
How we help you succeed
About us
Duncan Bucknell
Strategic Intellectual Property
Duncan
Posts by Duncan:
New Article – Novartis' glivec battle with India – patentability of pharmaceutical extension patents
New Article – Australia even more patent-friendly after High Court decision
Australia even more patent-friendly after High Court decision
Patent litigation in India – uncommon and in need of reform?
PubPat – the public interest patent challenger
Where (not) to litigate IP
Top Global Brands 2007
Participatory media & IP – great podcast
Lipitor (Zarator or Cardyl) in Spain – mixed success but no launch for Ranbaxy
What to do in the US if you don't have standing to sue for revocation – more on Benitec v Nucleonics
«
1
…
143
144
145
146
147
…
152
»
duncan@duncanbucknell.com
+61 427 003 423
Search
Search
Type your email…
Subscribe
Insights & News
Commercial IP, deals and contracts
Disputes and Litigation
IP Rights
Brands and Trade Marks
Copyright and Designs
Inventions & Patents
Trade Secrets
Strategic Advice
Coaching
Develop IP
Enforce and defend your IP
Increase IP Value
Inform and improve your IP Strategy
IP Management
Product Strategy
Pursue Excellence
Risk management
Loading Comments...
You must be
logged in
to post a comment.
You must be logged in to post a comment.